Home › 2 Bay Area biotechs set to test IPO market: Virobay, Atara Biotherapeutics
 

Keywords :   


2 Bay Area biotechs set to test IPO market: Virobay, Atara Biotherapeutics

2014-10-13 21:42:00| Biotech - Topix.net

Atara Biotherapeutics, led by Dr. Isaac Ciechanover, filed plans to raise up to $92 million this week in an IPO that was put off in July. The Bay Area's fourth-quarter IPO season swings back into action with a pair of biotech offerings this week from Atara Biotherapeutics and Virobay.

Tags: set area test market

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »